AGP Picks
View all

Specialist low-dose radiotherapy clinic opens in Alderley Edge

Nov. 16, 2026
Specialist low-dose radiotherapy clinic opens in Alderley Edge
By AI, Created 11:47 UTC, Nov 16, 2026, AGP -

A new consultant-led clinic has opened at Alderley Edge Medical Centre in Cheshire, offering low-dose radiotherapy for selected conditions including osteoarthritis, plantar fasciitis and tendonitis. The launch expands access to a treatment aimed at reducing pain and inflammation for patients who have not found enough relief from other therapies.

Why it matters: - The Alderley Edge clinic adds a local option for patients with chronic pain and inflammatory conditions who may be seeking alternatives to surgery or long-term medication. - Low-dose radiotherapy is being positioned for selected cases where symptoms affect mobility, sleep and day-to-day activity. - The service may matter most for patients whose physiotherapy, pain medication or other treatments have not provided enough relief.

What happened: - The Ergéa Alderley Edge Low-Dose Radiotherapy Clinic has opened at Alderley Edge Medical Centre in Cheshire. - The clinic offers consultant-led assessment and low-dose radiotherapy for selected conditions. - The clinic lists osteoarthritis, plantar fasciitis, Achilles and other tendinopathies, bursitis, tennis elbow, Dupuytren’s disease, Ledderhose disease and keloid scarring among the conditions it may treat. - Patients can contact the clinic directly, and referrals are also accepted from GPs, consultants and other healthcare professionals. - More information is available at the clinic website.

The details: - Low-dose radiotherapy uses carefully targeted, low doses of radiation. - The treatment aim varies by condition, but it is intended to reduce inflammation, improve mobility or help slow disease progression. - Each patient receives an individual clinical assessment before treatment is considered. - The assessment covers symptoms, previous treatments and whether LDRT is appropriate. - The clinic combines UK clinical expertise with experience from Ergéa’s wider network. - Ergéa is a pan-European specialist healthcare company operating through hospital partnerships and proprietary medical centres. - Ergéa says its radiotherapy centres in Germany treat more than 20,000 low-dose radiotherapy patients each year. - The clinic’s chief medical officer, Dr Richard Shaffer, is a consultant radiation oncologist with extensive experience in low-dose radiotherapy. - Dr Shaffer has treated more than 3,000 patients using LDRT. - Dr Shaffer co-authored Royal College of Radiologists guidelines on the treatment and trains and mentors other doctors in the field. - The clinic is led by chief executive officer Abe Elkinson, who has more than 20 years of experience developing and delivering patient-centred healthcare services in partnership with the NHS and other healthcare organisations.

Between the lines: - The clinic is aiming to make low-dose radiotherapy more visible as a non-surgical option for persistent pain and function-limiting conditions. - Ergéa is leaning on its international footprint and specialist experience to support a UK launch in a niche area of care. - The focus on consultant-led assessment suggests the clinic is positioning LDRT as a targeted treatment rather than a broad first-line option. - The leadership quotes frame the service around quality of life, not just symptom control.

What's next: - Patients with eligible conditions can seek assessment at the Alderley Edge site now. - The clinic is likely to build its patient base through both self-referral and professional referrals. - More information about Ergéa Group and Ergéa UK is available at the company website. - Ergéa UK operates in the UK as a vendor-independent provider of Managed Equipment Services and supports radiotherapy services across the country. - Ergéa currently operates in Germany, Italy, Luxembourg and the UK.

The bottom line: - Alderley Edge now has a specialist clinic offering low-dose radiotherapy for selected conditions, giving patients another pathway for managing chronic pain and inflammation.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

News From Europe!

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

News From Europe!

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.